Resources from the same session
Updated safety and efficacy of durvalumab (MEDI4736), an anti-PD-L 1 antibody, in patients from a squamous cell carcinoma of the head and neck (SCCHN) expansion cohort
Presenter: Neil Segal
Session: Head and neck cancers
Resources:
Abstract
Presentation
Webcast
Surrogate endpoints for overall survival in loco-regionally advanced nasopharyngeal carcinoma: Results from the individual patient data meta-analysis MAC-NPC2
Presenter: Federico Rotolo
Session: Head and neck cancers
Resources:
Abstract
Phase I trial of cetuximab, intensity modulated radiotherapy (IMRT), and ipilimumab in previously untreated, locally advanced head and neck squamous cell carcinoma (PULA HNSCC)
Presenter: Julie Bauman
Session: Head and neck cancers
Resources:
Abstract
PET-CT surveillance for advanced head and neck cancer: a cost-effective alternative to planned neck dissection?
Presenter: Alison Smith
Session: Head and neck cancers
Resources:
Abstract
Pembrolizumab after progression on platinum and cetuximab in head and neck squamous cell carcinoma (HNSCC): results from KEYNOTE-055
Presenter: Robert Haddad
Session: Head and neck cancers
Resources:
Abstract
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 100 randomized trials and 19,248 patients, on behalf of MACH-NC group
Presenter: Jean Bourhis
Session: Head and neck cancers
Resources:
Abstract
Invited discussant abstracts LBA36, 957PD and 955PD
Presenter: Ulrich Keilholz
Session: Head and neck cancers
Resources:
Presentation
Webcast
Invited discussant abstracts 952PD, 953PD and 956PD
Presenter: Ricard Mesia Nin
Session: Head and neck cancers
Resources:
Presentation
Webcast
Invited discussant abstracts 950O and 951O
Presenter: Ezra Cohen
Session: Head and neck cancers
Resources:
Presentation
Webcast
Final overall survival analysis of patients with locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer (RAI-rDTC) treated with sorafenib in the phase 3 DECISION trial: An exploratory crossover adjustment analyses
Presenter: Marcia Brose
Session: Head and neck cancers
Resources:
Abstract